Trial · NCT06027593
Results by group52
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 52
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Guideline-concordant Antibiotic Use for Adults With Pharyngitis | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 1458 | Participants | ||
| Guideline-concordant Antibiotic Use for Adults With Pharyngitis | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 2477 | Participants | ||
| Guideline-concordant Antibiotic Use for Children With Acute Otitis Media | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 6154 | Participants | ||
| Guideline-concordant Antibiotic Use for Children With Acute Otitis Media | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 6287 | Participants | ||
| Guideline-concordant Antibiotic Use for Adults With Community-acquired Pneumonia | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 204 | Participants | ||
| Guideline-concordant Antibiotic Use for Adults With Community-acquired Pneumonia | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 242 | Participants | ||
| Guideline-concordant Antibiotic Use for Children With Community-acquired Pneumonia | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 213 | Participants | ||
| Guideline-concordant Antibiotic Use for Children With Community-acquired Pneumonia | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 308 | Participants | ||
| Guideline-concordant Antibiotic Choice for Adults Hospitalized With Community Acquired Pneumonia | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 268 | Participants | ||
| Guideline-concordant Antibiotic Choice for Adults Hospitalized With Community Acquired Pneumonia | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 302 | Participants | ||
| Guideline-concordant Antibiotic Duration for Adults Hospitalized With Community Acquired Pneumonia | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 230 | Participants | ||
| Guideline-concordant Antibiotic Duration for Adults Hospitalized With Community Acquired Pneumonia | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 261 | Participants | ||
| 30-day Community Acquired Pneumonia-related Outpatient Revisits (Emergency Department, Urgent Care, or Primary Care) in Adults | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 0 | Participants | ||
| 30-day Community Acquired Pneumonia-related Outpatient Revisits (Emergency Department, Urgent Care, or Primary Care) in Adults | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 0 | Participants | ||
| 30-day Readmissions for Community Acquired Pneumonia in Adults | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 13 | Participants | ||
| 30-day Readmissions for Community Acquired Pneumonia in Adults | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 6 | Participants | ||
| Guideline-concordant Antibiotic Choice for Pediatric Community Acquired Pneumonia | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 394 | Participants | ||
| Guideline-concordant Antibiotic Choice for Pediatric Community Acquired Pneumonia | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 362 | Participants | ||
| Guideline-concordant Antibiotic Duration for Pediatric Community Acquired Pneumonia | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 221 | Participants | ||
| Guideline-concordant Antibiotic Duration for Pediatric Community Acquired Pneumonia | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 322 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06027593/results